INCELL CEO Provides Testimony at FDA on Human Cells and Tissues Manufacturing

September 12-13, 2016 – Washington DC, USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, has been selected to speak in Session 1 at the US Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Public Hearing on Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products.